Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort.

"CONFLICT OF INTEREST Ivica Ratosa, Nika Dobnikar, Michele Bottosso, Amélie Darlix, William Jacot, Stéphane Pouderoux, Domen Ribnikar, Léa Sinoquet and Tanja Znidaric report no conflict of interest. Maria Vittoria Dieci reports personal fees from Eli Lilly, MSD, Exact Sciences, Novartis, Pfizer, Seagen, outside the submitted work. Valentina Guarneri reports personal fees from Eli Lilly, Novartis, Roche, MSD, Gilead, Eisai (Advisory Board), and from Eli Lilly, Novartis, GSK, Amgen (Speakers' Bureau) outside the submitted work. Gaia Griguolo reports personal fees from Eli Lilly and Novartis (invited speaker), Gilead (Advisory Board) and from Novartis, Pfizer, Amgen, Daiichi Sankyo (Travel Support) outside the submitted work."

"Funding information 2019 Conquer Cancer Foundation of ASCO/Shanken Family Foundation Young Investigator Award; Fondazione AIRC under 5 per mille 2019, Grant/Award Number: 22759; Istituto Oncologico Veneto Projects, Grant/Award Numbers: L02P03, L04P11, L04P25; University of Padova – Department of Surgery, Oncology and Gastroenterology, Grant/Award Numbers: BIRD 2020, BIRD 2021"